Healthcare and technology start-ups remain hot property, but pandemic-fuelled uncertainty has led to lower valuations in some areas, such as travel-related platforms.
This is the third of six articles in Eastspring’s Asian Expert Series, which explores the future of Asia post Covid-19. The pandemic has exposed gaps in preparedness and health capacity globally that will trigger increased spending on healthcare infrastructure and research capabilities. Equally, it has revealed interesting investment possibilities as technology spawns new age healthtech entities.
More asset owners are looking to support healthcare private equity funds amid the pandemic. But aspiring funds also face rising competition, increasing asset costs and geopolitical risk.
State wealth funds look set to invest more at home thanks to the pandemic, but their increased allocations to healthcare and tech should prove beneficial, says a new report.
The firm's investment head for Asia says it's hard to find pure-play products for robotics and and cyber-security, which are both increasingly popular themes among clients.
Private equity firms in Greater China are exploiting the valuation differentials between China and markets such as the US, as well as between private and public markets.